Search PubMed⌕ Search

Biomedical subjects

B C Robertson

Publications and source records attributed to B C Robertson.

23 records · Page 2Linked to original sources

Genetic regulation of ribonucleoside and deoxyribonucleoside catabolism in Salmonella typhimurium.

Four enzymes involved in ribonucleoside and deoxyribonucleoside catabolism (deoxyribose-5-P aldolase, thymidine phosphorylase, phosphodeoxyribomutase, and purine nucleoside phosphorylase) are coded for by four closely linked structural genes on the Salmonella chromosome. The genetic order of these genes is (deoC-deoA-deoB-deoD)-serB-thr. Studies on polarity mutants and induction patterns indicate that the deoB and deoD genes may constitute a single operon and that the deoC and deoA genes may constitute a second closely linked operon.

Adenine↗

2-Deoxyribose gene-enzyme complex in Salmonella typhimurium: regulation of phosphodeoxyribomutase.

Phosphodeoxyribomutase, the enzyme which catalyzes the interconversion of 2-deoxyribose-1-phosphate to 2-deoxyribose-5-phosphate, has been partially purified from Salmonella typhimurium. The enzyme had an absolute requirement for manganese ion and was stimulated by glucose-1, 6-diphosphate. Phosphodeoxyribomutase was induced by deoxyribose-5-phosphate and was coordinately regulated with the enzymes thymidine phosphorylase and deoxyribose-5-phosphate aldolase, type II. Mutants deficient in these three enzymes were isolated and mapped close to the threonine locus in S. typhimurium. The three enzymes thymidine phosphorylase, deoxyribose-5-phosphate aldolase, type II, and phosphodeoxyribomutase are controlled by a series of linked genes and appear to constitute an operon.

Aldehyde-Lyases↗

Effects of EPO therapy on backfiltration of dialysate in high flux dialysis.

The authors have developed a comprehensive mathematical model of the hemodialysis process to investigate the effect of r-HuEPO and the accompanying higher hematocrit on backfiltration in high flux dialysis. Model simulations indicate that under otherwise identical conditions typical of high flux dialysis, an increase in hematocrit from 20 to 33% will increase the amount of dialysate fluid entering the blood from 2.4 L to 3.8 L in a 4 hr treatment. We used the mathematical model to investigate the effect of the following variables on backfiltration: blood flow rate, ultrafiltration rate, inside fiber diameter, fiber length, and membrane permeability. While increasing the blood flow rate may enhance solute transport, it was found to increase backfiltration substantially through its effect on the axial pressure drop. This effect was most pronounced at the higher hematocrits due to the higher viscosity. It was found that increasing the fiber ID, decreasing the fiber length, and decreasing the permeability of the membrane (all at constant surface area) could be beneficial in reducing backfiltration. However, these results do not consider the potential negative impact of these changes on solute clearance. Finally, the mathematical model enhanced our understanding of the transport processes governing backfiltration. Due to protein concentration gradients in the lumen, protein osmotic pressures as high as 50-100 mmHg can be obtained in high-flux dialysis. As a result, providing an outlet hydrostatic blood pressure greater than the inlet hydrostatic dialysate pressure is not sufficient to guarantee the absence of backfiltration.

Animals↗

A prescription model for peritoneal dialysis.

The authors have developed a mathematical model for peritoneal dialysis, based on the Popovich-Pyle-Moncrief approach, that is capable of predicting urea Kt/V and total weekly creatinine clearance for a variety of peritoneal dialysis therapies. This prescription model incorporates both diffusive and convective solute removal as well as ultrafiltration and lymphatic absorption. The primary input to the model is a single peritoneal equilibration test. Twenty-four hour dialysate collection is not required. Results from an extensive prospective clinical study performed with 100 patients at five dialysis centers indicate that the model is valid for predicting urea Kt/V and creatinine clearance for continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. Predicted clearances agree with the clinical data from these patients to within an average difference of approximately 10%. This model promises to be a powerful tool to assist nephrologists in quantifying the amount of peritoneal dialysis delivered by a given prescription, tailoring it to individual patient needs, and investigating the potential efficacy of a variety of alternative therapies.

Absorption↗